TYK2 and type 1 diabetes mellitus: This indicated that inhibition of TYK2, a kinase that transduces the early signals of IFNα and is a candidate gene for T1D (polymorphisms that decrease TYK2 signalling decrease disease risk), could revert the IFNα-induced signature.